Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Cirignano

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Family Physician|October 16, 2012
Transient ischemic attack: Part I. Diagnosis and evaluationB Brent Simmons, Barbara Cirignano, Annette B Gadegbeku
American Family Physician|October 16, 2012
Transient ischemic attack: Part II. Risk factor modification and treatmentB Brent Simmons, Annette B Gadegbeku, Barbara Cirignano
International Journal of Cancer|March 18, 2004
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansionKavita M Dhodapkar, Barbara Cirignano, Francesca Chamian, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Family Physician|October 16, 2012
Transient ischemic attack: Part I. Diagnosis and evaluationB Brent Simmons, Barbara Cirignano, Annette B Gadegbeku
American Family Physician|October 16, 2012
Transient ischemic attack: Part II. Risk factor modification and treatmentB Brent Simmons, Annette B Gadegbeku, Barbara Cirignano
International Journal of Cancer|March 18, 2004
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansionKavita M Dhodapkar, Barbara Cirignano, Francesca Chamian, et al.
Pageof 1